Literature DB >> 4983754

Prevention of meningococcal disease by group C polysaccharide vaccine.

M S Artenstein, R Gold, J G Zimmerly, F A Wyle, H Schneider, C Harkins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4983754     DOI: 10.1056/NEJM197002192820803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  89 in total

1.  Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.

Authors:  Joseph Martinez; Tamara Pilishvili; Suzanne Barnard; Joseph Caba; Willie Spear; Sandra Romero-Steiner; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Meningococcal group C conjugate vaccines.

Authors:  J Maclennan
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

3.  Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source.

Authors:  C J Gill; S Ram; J A Welsch; L Detora; A Anemona
Journal:  Vaccine       Date:  2011-11-07       Impact factor: 3.641

Review 4.  Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.

Authors:  Idris Mohammed; Garba Iliyasu; Abdulrazaq Garba Habib
Journal:  Pathog Glob Health       Date:  2017-01-12       Impact factor: 2.894

5.  Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults.

Authors:  D M Ambrosino; V A Barrus; G G DeLange; G R Siber
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.

Authors:  G R Siber; D M Ambrosino; J McIver; T J Ervin; G Schiffman; S Sallan; G F Grady
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

7.  Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

Authors:  E L Anderson; T Bowers; C M Mink; D J Kennedy; R B Belshe; H Harakeh; L Pais; P Holder; G M Carlone
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Genital antibody response to a parenteral gonococcal pilus vaccine.

Authors:  D McChesney; E C Tramont; J W Boslego; J Ciak; J Sadoff; C C Brinton
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

9.  Epidemiologic characteristics of an outbreak of serogroup C meningococcal disease and the public health response.

Authors:  P Houck; M Patnode; R Atwood; K Powell
Journal:  Public Health Rep       Date:  1995 May-Jun       Impact factor: 2.792

Review 10.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.